BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19456032)

  • 21. Treatment of peritoneal mesothelioma in pediatric patients.
    Cioffredi LA; Jänne PA; Jackman DM
    Pediatr Blood Cancer; 2009 Jan; 52(1):127-9. PubMed ID: 18819151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potential therapeutic strategy for malignant mesothelioma with gene medicine.
    Tada Y; Shimada H; Hiroshima K; Tagawa M
    Biomed Res Int; 2013; 2013():572609. PubMed ID: 23484132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New diagnostic and molecular characteristics of malignant mesothelioma.
    Davidson B
    Ultrastruct Pathol; 2008; 32(6):227-40. PubMed ID: 19117264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etiology, epidemiology, biology. Occupational respiratory cancers].
    Pairon JC; Andujar P; Matrat M; Ameille J
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S18-31. PubMed ID: 18971823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mesothelioma in academics. German Bochum mesothelioma register].
    Müller KM; Dernbach AB; Neumann V
    Chirurg; 2008 Mar; Suppl():99-102. PubMed ID: 18711823
    [No Abstract]   [Full Text] [Related]  

  • 27. Malignant pleural mesothelioma initially diagnosed on cervical lymph node biopsy.
    Ogata S; Hiroi S; Tominaga A; Aida S; Kobayashi A; Tamura K; Abe Y; Kawai T
    Pathol Int; 2009 Aug; 59(8):592-4. PubMed ID: 19627545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-associated macrophages in thoracic malignancies.
    Lievense LA; Bezemer K; Aerts JG; Hegmans JP
    Lung Cancer; 2013 Jun; 80(3):256-62. PubMed ID: 23489559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic options in malignant mesothelioma.
    Moreno de la Santa P; Butchart EG
    Curr Opin Oncol; 1995 Mar; 7(2):134-7. PubMed ID: 7538792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acne inversa complicated by squamous cell carcinoma in association with diffuse malignant peritoneal mesothelioma arising in the absence of predisposing factors: a case report.
    Barresi V; Vitarelli E; Barresi G
    J Cutan Pathol; 2008 Jan; 35(1):70-3. PubMed ID: 18095999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Under-reporting of compensable mesothelioma in Alberta.
    Cree MW; Lalji M; Jiang B; Carriere KC
    Am J Ind Med; 2009 Jul; 52(7):526-33. PubMed ID: 19484745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies.
    Patel A; Anraku M; Darling GE; Shepherd FA; Pierre AF; Waddell TK; Keshavjee S; de Perrot M
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):843-8. PubMed ID: 19660355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening for asbestos-related conditions].
    Brauer C; Baandrup U; Jacobsen P; Krasnik M; Olsen JH; Pedersen JH; Rasmussen TR; Schlünssen V; Sherson D; Svolgaard B; Sørensen JB; Omland O
    Ugeskr Laeger; 2009 Feb; 171(6):433-6. PubMed ID: 19208334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis in related pathologic asbestosis, clinical case of a suspected occupational neoplasm].
    Spigno F; Gentile R; Valente T; Capannelli G
    G Ital Med Lav Ergon; 2008; 30(4):324-8. PubMed ID: 19344083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recurrent benign cystic peritoneal mesothelioma].
    Stroescu C; Negulescu R; Herlea V; David L; Ivanov B; Nitipir C; Popescu I
    Chirurgia (Bucur); 2008; 103(6):715-8. PubMed ID: 19274921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials.
    Francart J; Vaes E; Henrard S; Legrand C; Baas P; Gaafar R; van Meerbeeck JP; Sylvester R; Robert A
    Eur J Cancer; 2009 Sep; 45(13):2304-11. PubMed ID: 19502050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair systems in malignant mesothelioma.
    Toumpanakis D; Theocharis SE
    Cancer Lett; 2011 Dec; 312(2):143-9. PubMed ID: 21930342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activity of the Campania Register of Mesothelioma from July 2003 to October 2007].
    Menegozzo M; Izzo F; Canfora ML; Petronzio MF; Menegozzo S
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):642-4. PubMed ID: 18409884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression.
    Spugnini EP; Bosari S; Citro G; Lorenzon I; Cognetti F; Baldi A
    Int J Biochem Cell Biol; 2006; 38(12):2000-4. PubMed ID: 16963313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case of malignant mesothelioma in a 32-year-old mulliparous woman].
    Szczurowicz A; Pytlik M; Pośpiech J
    Wiad Lek; 1978 Dec; 31(23):1701-3. PubMed ID: 735080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.